SHSE:688319 (China)
Â
Class A
Â¥
11.72
(-0.09%)
Nov 28
Business Description
Chengdu Olymvax Biopharmaceuticals Inc
ISIN : CNE1000051H8
Share Class Description:
SHSE:688319: Class ACompare
Compare
Traded in other countries / regions
688319.China IPO Date
2021-06-08Description
Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.71 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.42 | |||||
| Debt-to-EBITDA | 1830.79 | |||||
| Interest Coverage | 0.32 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 4.15 | |||||
| Beneish M-Score | -2.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.7 | |||||
| 3-Year EBITDA Growth Rate | -4 | |||||
| 3-Year EPS without NRI Growth Rate | -58.9 | |||||
| 3-Year FCF Growth Rate | -85 | |||||
| 3-Year Book Growth Rate | 29.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 214.14 | |||||
| Future 3-5Y Total Revenue Growth Rate | 22.64 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.17 | |||||
| 9-Day RSI | 65.06 | |||||
| 14-Day RSI | 61.69 | |||||
| 6-1 Month Momentum % | 17 | |||||
| 12-1 Month Momentum % | -44.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.86 | |||||
| Quick Ratio | 1.67 | |||||
| Cash Ratio | 0.56 | |||||
| Days Inventory | 1071.29 | |||||
| Days Sales Outstanding | 340.95 | |||||
| Days Payable | 619.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.32 | |||||
| Dividend Payout Ratio | 5.43 | |||||
| Forward Dividend Yield % | 0.32 | |||||
| 5-Year Yield-on-Cost % | 0.32 | |||||
| 3-Year Average Share Buyback Ratio | -3.7 | |||||
| Shareholder Yield % | -3.16 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 94.84 | |||||
| Operating Margin % | 0.78 | |||||
| Net Margin % | -1.64 | |||||
| FCF Margin % | -48.44 | |||||
| ROE % | -0.96 | |||||
| ROA % | -0.54 | |||||
| ROIC % | 0.46 | |||||
| ROC (Joel Greenblatt) % | 0.03 | |||||
| ROCE % | 0.02 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 69.51 | |||||
| PE Ratio without NRI | 1677.14 | |||||
| PS Ratio | 9 | |||||
| PB Ratio | 5.23 | |||||
| Price-to-Tangible-Book | 7.33 | |||||
| EV-to-EBIT | 23531.95 | |||||
| EV-to-EBITDA | 23531.95 | |||||
| EV-to-Revenue | 9.18 | |||||
| EV-to-FCF | -18.96 | |||||
| Price-to-Graham-Number | 23.44 | |||||
| Price-to-Net-Current-Asset-Value | 46.88 | |||||
| FCF Yield % | -5.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chengdu Olymvax Biopharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 530.466 | ||
| EPS (TTM) (Â¥) | -0.021 | ||
| Beta | 1.43 | ||
| Volatility % | 47.98 | ||
| 14-Day RSI | 61.69 | ||
| 14-Day ATR (Â¥) | 0.564372 | ||
| 20-Day SMA (Â¥) | 10.8915 | ||
| 12-1 Month Momentum % | -44.22 | ||
| 52-Week Range (Â¥) | 7.06 - 20.4 | ||
| Shares Outstanding (Mil) | 405.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chengdu Olymvax Biopharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chengdu Olymvax Biopharmaceuticals Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chengdu Olymvax Biopharmaceuticals Inc Frequently Asked Questions
What is Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319)'s stock price today?
The current price of SHSE:688319 is ¥11.72. The 52 week high of SHSE:688319 is ¥20.40 and 52 week low is ¥7.06.
When is next earnings date of Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319)?
The next earnings date of Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) is .
Does Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) pay dividends? If so, how much?
The Dividend Yield %  of Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) is 0.32% (As of Today), Highest Dividend Payout Ratio of Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) was 5.43. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) is 0.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers